Apes. Together. Strong.

I hope y'all are proud of this. You really should be.

Charles Kung, PhD, presenting REM-422, a first-in-class, orally available small molecule degrader of MYB mRNA at #AACR today. REM-422 induces tumor regressions in MYB-dysregulated preclinical models at well tolerated doses & is in two Phase 1 clinical trials. bit.ly/4c4FkAr

Great to have Linda on board!

On International Day of Women & Girls in Science, we celebrate the impact of women in STEM and the importance of future opportunities. To mark the occasion, Remixers enjoyed lunch from Powerhouse Café, a woman-owned caterer. We’re proud to support women in science, business, and beyond!🚀

Five Breakthroughs In 2024 That Laid A Foundation For Future Tech From transforming coal to computing with DNA to pharmaceutical manufacturing in space, these are the discoveries that will set the stage for the next decade’s technology.

Congratulations to Prof. Juan Valcarcel at the @crg.eu and #Remixers Fred Vaillancourt and Bryan Dunyak. Work from our collaboration was selected in Forbes' Five Breakthroughs of 2024 That Laid A Foundation For Future Tech! Read the full article here: bit.ly/3DPYnBG

As the year draws to a close, we want to extend our heartfelt appreciation to our dedicated team, valued partners, and the
patients we serve. We are incredibly proud of the progress we’ve made this year in advancing the field of
#SmallMolecule therapies. #YearInReview #TrueToOurRNA

👏 Let's give it up for #Remixer Sam Levin-Furtney, who delivered an incredible talk at the ASH conference this year! #CourageousCuriosity #ASH2024